Updated data show a second partial response in Part B Overall response rate of 15.4% and disease control rate of…
Trial targeted to begin in the first quarter of 2022NRx is coordinating study with the US Health and Human Services…
Anticipates Record Full-Year Net Revenue of $10.4 Million, a 21% Year-Over-Year Increase and Fourth Quarter Revenue of $2.8 Million, an…
EWING, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today…
Data highlight key pharmacokinetic properties of serdexmethylphenidate that are instrumental to its consistent and smooth release of d-MPH CELEBRATION, Fla.,…
New collaboration builds on existing relationship between the two companies to develop desktop systems for the clinical market in China…
– 600,000 additional doses to be supplied to the US government for distribution in Q1 2022, enabling further access to sotrovimab…
Pilot project designed to demonstrate the power of HiFi sequencing to effectively and efficiently identify novel variants following short-read genome…
Initial proof-of-concept work suggests strong potential to further improve PacBio’s highly accurate HiFi Sequencing with Google deep learning technologiesMENLO PARK,…
BBS-Bioactive Bone Substitutes Plc, Company announcement, inside information, 11th January 2022 at 14:00 EET BBS-Bioactive Bone Substitutes Plc: US Patent…